ADMA BIOLOGICS, INC. Current Income Tax Expense (Benefit)
ADMA BIOLOGICS, INC. (ADMA) reported Current Income Tax Expense (Benefit) of $24.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-25
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for the quarter ending 2013-03-31 was $0.00.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for the quarter ending 2012-12-31 was $0.00.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for the quarter ending 2012-09-30 was $0.00.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for the quarter ending 2012-06-30 was $0.00.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for fiscal 2025 was $24.71M, a 100.52% increase from fiscal 2024.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for fiscal 2024 was $12.32M.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for fiscal 2023 was $0.00.
- ADMA BIOLOGICS, INC. current income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.71M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $12.32M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-18 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-23 | |||
| 2014-12-31 | -$551.72K 10-K · filed 2016-03-23 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-09 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 derived: sum of 4 quarters · filed 2014-03-28 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | -$617.62K 10-K · filed 2014-03-28 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-08-12 | -$617.62K 10-Q · filed 2013-11-12 | -$617.62K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$617.62K 10-Q · filed 2013-08-12 | -$617.62K derived: sum of 3 quarters · filed 2013-08-12 | -$617.62K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | -$617.62K 10-Q · filed 2013-05-14 | -$617.62K derived: sum of 2 quarters · filed 2013-05-14 | -$617.62K derived: sum of 3 quarters · filed 2013-05-14 | -$617.62K derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $0.00 derived: sum of 2 quarters · filed 2013-03-06 | $0.00 derived: sum of 3 quarters · filed 2013-03-06 | -$320.76K 10-K · filed 2013-03-06 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | -$320.76K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$320.76K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | -$320.76K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |